Format

Send to

Choose Destination
Ann Intern Med. 2012 Jan 17;156(2):115-22. doi: 10.7326/0003-4819-156-2-201201170-00006.

Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study.

Author information

1
Valme University Hospital, Seville, Spain. fracamrod@gmail.com

Abstract

BACKGROUND:

Obstructive sleep apnea (OSA) is a risk factor for cardiovascular death in men, but whether it is also a risk factor in women is unknown.

OBJECTIVE:

To investigate whether OSA is a risk factor for cardiovascular death in women and assess whether continuous positive airway pressure (CPAP) treatment is associated with a change in risk.

DESIGN:

Prospective, observational cohort study.

SETTING:

2 sleep clinics in Spain.

PATIENTS:

All women consecutively referred for suspected OSA between 1998 and 2007.

INTERVENTION:

Every woman had a diagnostic sleep study. Women with an apnea-hypopnea index (AHI) less than 10 were the control group. Obstructive sleep apnea was diagnosed when the AHI was 10 or higher (classified as mild to moderate [AHI of 10 to 29] or severe [AHI ≥30]). Patients with OSA were classified as CPAP-treated (adherence ≥4 hours per day) or untreated (adherence <4 hours per day or not prescribed). Participants were followed until December 2009.

MEASUREMENTS:

The end point was cardiovascular death.

RESULTS:

1116 women were studied (median follow-up, 72 months [interquartile range, 52 to 88 months]). The control group had a lower cardiovascular mortality rate (0.28 per 100 person-years [95% CI, 0.10 to 0.91]) than the untreated groups with mild to moderate OSA (0.94 per 100 person-years [CI, 0.10 to 2.40]; P = 0.034) or severe OSA (3.71 per 100 person-years [CI, 0.09 to 7.50]; P < 0.001). Compared with the control group, the fully adjusted hazard ratios for cardiovascular mortality were 3.50 (CI, 1.23 to 9.98) for the untreated, severe OSA group; 0.55 (CI, 0.17 to 1.74) for the CPAP-treated, severe OSA group; 1.60 (CI, 0.52 to 4.90) for the untreated, mild to moderate OSA group; and 0.19 (CI, 0.02 to 1.67) for the CPAP-treated, mild to moderate OSA group.

LIMITATION:

The study was observational and not randomized, and OSA was diagnosed by 2 different methods.

CONCLUSION:

Severe OSA is associated with cardiovascular death in women, and adequate CPAP treatment may reduce this risk.

PRIMARY FUNDING SOURCE:

None.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center